Drug intelligence / Profile preview

retinalamin

Development stage: Unknown
Lead developer: Saint Petersburg Institute of Bioregulation and Gerontology
Modality: Peptides
Administration: Intramuscular, Parabulbar

Overview

Retinalamin is a tissue-specific peptide bioregulator and retinoprotector developed by the Saint Petersburg Institute of Bioregulation and Gerontology. It consists of a complex of water-soluble polypeptide fractions isolated from the retina of cattle (bovine). Retinalamin is designed to regulate metabolic processes in the retina, stimulate the repair and functional activity of retinal cells, and improve the interaction between the retinal pigment epithelium and photoreceptors. It also exhibits anti-inflammatory and antioxidant properties, enhances the activity of retinal macrophages, and protects the vascular endothelium. The drug is approved in Russia for the treatment of various degenerative and vascular retinal diseases, including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa.

Brand names: RetinalaminРетиналамин
Other names: Retinalaminumretina-derived polypeptide complex

Beyond the preview

Go deeper on retinalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on retinalamin.

Explore the full profile